EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Auer rod‐positive acute leukemia with predominantly lymphoid immunophenotype: Report on 11 cases and review of literature

Ondrej Hrusak iD, Jitka Stancikova iD, Elena Vodickova, Tereza Podolska iD, Anja Möricke, Andishe Attarbaschi iD, Michael Dworzak iD, Zuzana Sestakova iD, Peter Svec iD, Marketa Kubricanova Zaliova iD, Iveta Janotova, Ondrej Zapletal iD und 2 weitere

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Ondrej Hrusak und 13 weiteren Autor:innen. Beteiligte Einrichtung: CLIP, Charles University, Prague, Czech Republic. Hauptthemen laut MEDLINE: Immunophenotyping. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Univerzita Karlova v Praze, European Union and state budget of Czechia, Ministerstvo Zdravotnictví Ceské Republiky.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Auer rods (AuRs) are prominent intracellular structures found almost exclusively in myeloid cell malignancies, such as acute myeloid leukemia (AML), chronic and juvenile myelomonocytic leukemia and myelodysplastic syndrome. Extremely rare AuRs have been reported in patients with acute lymphoblastic leukemia (ALL) or among ambiguous lineage leukemia patients with a dominantly lymphoblastic immunophenotype. Procedure We report diagnostic and follow‐up data of an international cohort of 11 children suffering from leukemias with AuRs and with significant presence of T and myeloid markers, majority of whom categorized as early T‐cell precursor (ETP, n = 7); or T‐ALL (ETP status unknown, n = 2), ALAL (acute leukemia of ambiguous lineage, n = 1), and AML reclassified from ALAL ( n = 1). We described other diagnostic details and treatment types and responses. Moreover, we summarize previously published data.

Results

Among the four patients who started and remained on ALL‐type therapy, all were in the first complete remission, whereas both patients who started and remained on AML‐type therapy relapsed and died. Of the patients who followed either a combined ALL/AML protocol (Interfant 06) or who switched from one of the two types of therapy to the other, one patient died, and the remaining four were in first complete remission at the most recent follow‐up. We also searched for similar cases in the literature and found only three additional children with nonmyeloid leukemia and AuRs and 10 adults with this type of leukemia.

Conclusions

Briefly, ALL‐ or combined ALL/AML‐type therapy may be effective for treating AuR‐positive leukemia patients with a lymphoid immunophenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunophenotypingAdolescentChildChild, PreschoolFemaleHumansInfantMaleFollow-Up StudiesLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma

Stichwörter der Autor:innen

Auer rodsbiphenotypic acute leukemiaearly T‐cell precursor lymphoblastic leukemia

Autor:innen und Institutionen

  • CLIP, Charles University, Prague, Czech Republic.
  • Department of Pediatric Hematology and Oncology, Motol Hospital, Prague, Czech Republic.
  • Department of Clinical Hematology, Motol Hospital, Prague, Czech Republic.
  • Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic.
  • Department of Paediatrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.

ORCID-Profile: Ondrej Hrusak, Jitka Stancikova, Tereza Podolska, Andishe Attarbaschi, Michael Dworzak, Zuzana Sestakova, Peter Svec, Marketa Kubricanova Zaliova, Ondrej Zapletal, Ester Mejstrikova, Jan Stary

Förderung

  • Univerzita Karlova v Praze
  • European Union and state budget of Czechia
  • Ministerstvo Zdravotnictví Ceské Republiky

Zitieren

APA

Hrusak, O., Stancikova, J., Vodickova, E., Podolska, T., Möricke, A., Attarbaschi, A., Dworzak, M., Sestakova, Z., Svec, P., Zaliova, M. K., Janotova, I., Zapletal, O., Mejstrikova, E., & Stary, J. (2025). Auer rod‐positive acute leukemia with predominantly lymphoid immunophenotype: Report on 11 cases and review of literature. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31394

Vancouver

Hrusak O, Stancikova J, Vodickova E, Podolska T, Möricke A, Attarbaschi A, et al. Auer rod‐positive acute leukemia with predominantly lymphoid immunophenotype: Report on 11 cases and review of literature. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31394

BibTeX
@article{Hrusak2025,
  author = {Hrusak, Ondrej and Stancikova, Jitka and Vodickova, Elena and Podolska, Tereza and Möricke, Anja and Attarbaschi, Andishe and Dworzak, Michael and Sestakova, Zuzana and Svec, Peter and Zaliova, Marketa Kubricanova and Janotova, Iveta and Zapletal, Ondrej and Mejstrikova, Ester and Stary, Jan},
  title = {Auer rod‐positive acute leukemia with predominantly lymphoid immunophenotype: Report on 11 cases and review of literature},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31394}
}
Kostenlos starten →